Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | MCP-1 (MCAF) | 4795.0 | 79 | |
| N2586 | 1 | MCP-1 (MCAF) | 6802.0 | 79 | |||||||
| RA2159 | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 2083.0 | 74 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 1182.0 | 71 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 1293.0 | 70 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 2250.5 | 60 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 2297.0 | 68 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 897.5 | 88 | |
| N2586 | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 6064.0 | 65 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 7055.5 | 58 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 4695.0 | 57 | |
| N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 5382.5 | 60 | |
| N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 5973.0 | 67 | |
| N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | MCP-1 (MCAF) | 6321.0 | 62 | |
| RA2159 | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2363.0 | 81 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 1483.0 | 61 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 1607.0 | 71 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2585.0 | 57 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 2500.0 | 85 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 1012.5 | 68 | |
| N2586 | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 7355.0 | 52 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 6047.5 | 60 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 4394.0 | 83 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 6530.0 | 66 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | MCP-1 (MCAF) | 7152.0 | 79 |